Shares

37 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$1.11 - $2.88 $984,705 - $2.55 Million
-887,122 Closed
0 $0
Q1 2023

May 15, 2024

BUY
$1.51 - $3.25 $421,290 - $906,750
279,000 New
279,000 $421,000
Q4 2022

Feb 14, 2023

BUY
$2.25 - $4.67 $627,750 - $1.3 Million
279,000 New
279,000 $697,000
Q2 2022

Aug 14, 2023

BUY
$2.3 - $6.29 $2.04 Million - $5.58 Million
887,122 New
887,122 $2.48 Million
Q1 2022

May 12, 2023

BUY
$4.63 - $9.94 $2.52 Million - $5.41 Million
544,322 Added 195.1%
823,322 $4.71 Million
Q1 2022

May 09, 2022

SELL
$4.63 - $9.94 $3.75 Million - $8.04 Million
-808,960 Closed
0 $0
Q4 2021

Mar 09, 2022

BUY
$8.35 - $12.6 $6.75 Million - $10.2 Million
808,960 New
808,960 $7.39 Million
Q3 2021

Nov 14, 2022

BUY
$10.13 - $15.0 $8.19 Million - $12.1 Million
808,865 New
808,865 $8.65 Million
Q3 2021

Nov 05, 2021

SELL
$10.13 - $15.0 $6.08 Million - $9 Million
-599,865 Closed
0 $0
Q2 2021

Aug 15, 2022

BUY
$13.27 - $18.48 $7.96 Million - $11.1 Million
599,865 New
599,865 $9.31 Million
Q2 2021

Aug 10, 2021

SELL
$13.27 - $18.48 $7.95 Million - $11.1 Million
-599,119 Closed
0 $0
Q1 2021

May 09, 2022

BUY
$14.49 - $20.72 $8.68 Million - $12.4 Million
599,119 New
599,119 $9.71 Million
Q1 2021

May 07, 2021

SELL
$14.49 - $20.72 $16.9 Million - $24.2 Million
-1,166,605 Closed
0 $0
Q4 2020

Mar 02, 2021

BUY
$14.61 - $22.14 $17 Million - $25.8 Million
1,166,605 New
1,166,605 $24.7 Million
Q4 2020

Feb 10, 2021

SELL
$14.61 - $22.14 $20.2 Million - $30.6 Million
-1,380,271 Closed
0 $0
Q3 2020

Nov 12, 2021

BUY
$13.67 - $17.77 $18.9 Million - $24.5 Million
1,380,271 New
1,380,271 $20.5 Million
Q3 2020

Nov 10, 2020

SELL
$13.67 - $17.77 $20.3 Million - $26.4 Million
-1,484,415 Closed
0 $0
Q2 2020

Aug 13, 2021

BUY
$10.89 - $21.47 $16.2 Million - $31.9 Million
1,484,415 New
1,484,415 $21.8 Million
Q2 2020

Aug 07, 2020

SELL
$10.89 - $21.47 $12.3 Million - $24.3 Million
-1,129,998 Closed
0 $0
Q1 2020

May 07, 2021

BUY
$10.23 - $24.56 $11.6 Million - $27.8 Million
1,129,998 New
1,129,998 $13.3 Million
Q1 2020

May 08, 2020

SELL
$10.23 - $24.56 $10.2 Million - $24.4 Million
-995,080 Closed
0 $0
Q4 2019

Mar 03, 2020

BUY
$17.42 - $26.61 $17.3 Million - $26.5 Million
995,080 New
995,080 $23.4 Million
Q4 2019

Feb 12, 2020

SELL
$17.42 - $26.61 $14 Million - $21.3 Million
-801,791 Closed
0 $0
Q3 2019

Nov 13, 2020

BUY
$16.36 - $21.39 $13.1 Million - $17.2 Million
801,791 New
801,791 $14.8 Million
Q3 2019

Nov 08, 2019

SELL
$16.36 - $21.39 $11.9 Million - $15.5 Million
-725,523 Closed
0 $0
Q2 2019

Aug 13, 2020

BUY
$16.93 - $26.22 $12.3 Million - $19 Million
725,523 New
725,523 $13.5 Million
Q2 2019

Aug 09, 2019

SELL
$16.93 - $26.22 $11 Million - $17 Million
-647,140 Closed
0 $0
Q1 2019

May 11, 2020

BUY
$23.15 - $28.34 $2.77 Million - $3.39 Million
119,789 Added 22.72%
647,140 $15.8 Million
Q4 2018

Mar 04, 2019

BUY
$22.03 - $32.01 $11.6 Million - $16.9 Million
527,351 New
527,351 $13.7 Million
Q4 2018

Feb 08, 2019

SELL
$22.03 - $32.01 $10.1 Million - $14.6 Million
-456,439 Closed
0 $0
Q3 2018

Nov 12, 2019

BUY
$30.0 - $40.85 $13.7 Million - $18.6 Million
456,439 New
456,439 $14.4 Million
Q3 2018

Nov 09, 2018

SELL
$30.0 - $40.85 $1.5 Million - $2.04 Million
-50,000 Closed
0 $0
Q2 2018

Aug 12, 2019

BUY
$26.4 - $42.0 $1.32 Million - $2.1 Million
50,000 New
50,000 $1.94 Million
Q4 2017

Feb 09, 2018

SELL
$14.8 - $18.85 $296,000 - $377,000
-20,000 Closed
0 $0
Q3 2017

Nov 13, 2018

BUY
$14.65 - $16.85 $293,000 - $337,000
20,000 New
20,000 $323,000
Q3 2017

Nov 07, 2017

SELL
$14.65 - $16.85 $293,000 - $337,000
-20,000 Closed
0 $0
Q1 2017

May 11, 2018

BUY
N/A
20,000
20,000 $300,000

Others Institutions Holding HRTX

About HERON THERAPEUTICS, INC.


  • Ticker HRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,774,000
  • Market Cap $184M
  • Description
  • Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...
More about HRTX
Track This Portfolio

Track Norges Bank Portfolio

Follow Norges Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.